Physician profile
Yi J Zhang
NPI 1083666978
$757,532.00
in general payments reported to CMS, 2019-2025
27 companies · $65K in 2025
The $65K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $116K · 2021: $128K · 2022: $145K · 2023: $124K · 2024: $153K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150K · Consulting Fee: $99K · Travel and Lodging: $77K · Food and Beverage: $15K · Education: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $149,509.29 |
| Consulting Fee | $99,277.92 |
| Travel and Lodging | $77,030.83 |
| Food and Beverage | $15,411.21 |
| Education | $595.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $714,500.46 | 2019-2025 | Web Aneurysm Embolization System, Stent, Hydrosoft Advanced |
| Stryker Corporation | $22,418.37 | 2020-2025 | Broadway 8, Synchro Select, Surpass Evolve |
| Medical Device Business Services, INC. | $10,750.82 | 2025 | Spotlight |
| Silk Road Medical, INC. | $1,868.98 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Depuy Synthes Sales INC. | $1,721.50 | 2019-2025 | Trufill, Embotrap, Cerepak Uniform |
| Medtronic, INC. | $1,433.49 | 2022-2025 | Pipeline, Protege Rx, Onyx 18 |
| Penumbra, INC. | $938.40 | 2020-2024 | Penumbra System, Red 72, Penumbra Coil 400 |
| Imperative Care, INC | $735.38 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom 7x Catheter, Zoom Reperfusion Catheter |
| Balt USA, LLC | $595.52 | 2021-2024 | Optima Coil System |
| Scientia Vascular | $486.63 | 2023-2024 | Socrates 38 |
| Rapid Medical LTD | $270.25 | 2022-2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Medtronic USA, INC. | $240.42 | 2019-2020 | |
| Maduro Medical, INC. | $238.06 | 2025 | |
| Nuvasive, INC. | $233.37 | 2019 | |
| Inari Medical, INC. | $220.68 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $177.88 | 2023 | Corpath Imaging System |
| Boston Scientific Corporation | $154.57 | 2025 | Enroute Transcarotid Neuroprotection System |
| Providence Medical Technology, INC. | $132.67 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $124.15 | 2020 | |
| Qapel Medical INC | $93.41 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $54.49 | 2019 | |
| Sunovion Pharmaceuticals INC. | $38.38 | 2019-2020 | |
| Contego Medical, INC | $26.85 | 2024 | |
| Sirtex Medical INC | $23.95 | 2025 | Sir-Spheres Microspheres |
| Lundbeck LLC | $19.49 | 2024 | Rexulti |
| Ethicon US, LLC | $18.83 | 2023 | Surgicel Nu-Knit |
| Abbvie INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.